FNF · Fidelity National Financial, Inc.
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Dec 17, 2025; bars on opposite sides are not compared.
The closing range begins at the captured split on Dec 17, 2025.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Agency title premiums | $967M | FY2026 Q2 | +15.3% |
|
|
|||
| Direct title premiums | $767M | FY2026 Q2 | +21.4% |
|
|
|||
| Adjusted net earnings non-GAAP | $370M | Q2 2026 | — |
|
|
|||
| Adjusted net earnings per share non-GAAP | $1.39 | Q2 2026 | — |
|
|
|||
| Adjusted pre-tax title margin non-GAAP | 17.8% | Q2 2026 | — |
|
|
|||
| Capital returned to shareholders | $195M | Q2 2026 | — |
| F&G AUM before reinsurance non-GAAP | 74.7B | Q2 2026 | — |
|
|
|||
| F&G gross sales non-GAAP | 2.7B | Q2 2026 | — |
|
|
|||
| F&G net sales non-GAAP | 1.5B | Q2 2026 | — |
|
|
|||
| Weighted average common diluted shares | 267M | Q2 2026 | — |
|
|
|||
| Commercial revenue | $338M | Three Months Ended March 31, 2026 | — |
| F&G assets under management (AUM) non-GAAP | $56.44B | Three Months Ended March 31, 2026 | — |
|
|
|||
| Total common shares outstanding | 269M | Three Months Ended March 31, 2026 | — |
| F&G AUM before flow reinsurance non-GAAP | $73.09B | Q4 2025 | — |
| Total fee per file | $4,099 | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Specialty — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FNF
this stock
Fidelity National Financial, Inc.
|
$13.27B | -9.4% | +5.6% | — | 3.4% |
|
RYAN
Ryan Specialty Holdings, Inc.
|
$10.97B | -19.0% | +21.3% | — | 5.2% |
|
FAF
First American Financial Corp
|
$7.54B | +20.2% | +21.6% | 10.2 | 5.8% |
|
AXS
Axis Capital Holdings Ltd
|
$7.46B | -5.5% | +10.2% | 7.6 | 2.7% |
|
ACT
Enact Holdings, Inc.
|
$6.86B | +26.0% | +2.8% | 10.5 | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Dec 17, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FNF | -1.4% | -4.7% | -3.1% | -4.1% | -9.4% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -1.8% | -9.1% | -16.8% | -8.0% | -23.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.